(Q42932513)

11 November 2017

Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro (English)

1 reference

11 November 2017

1 reference

Masayuki Tsujimoto

1

1 reference

11 November 2017

Keishi Higuchi

2

1 reference

11 November 2017

Daisuke Shima

3

1 reference

11 November 2017

Hitoshi Yokota

4

1 reference

11 November 2017

Taku Furukubo

5

1 reference

11 November 2017

Satoshi Izumi

6

1 reference

11 November 2017

Tomoyuki Yamakawa

7

1 reference

11 November 2017

Masaki Otagiri

8

1 reference

11 November 2017

Sumio Hirata

9

1 reference

11 November 2017

Kohji Takara

10

1 reference

11 November 2017

Kohshi Nishiguchi

11

1 reference

11 November 2017

language of work or name

1 reference

1 January 2010

1 reference

Journal of Pharmacy and Pharmacology

11 November 2017

1 reference

11 November 2017

62

1 reference

11 November 2017

1

1 reference

11 November 2017

133-138

1 reference

Pharmacokinetics and blood pressure response of losartan in end-stage renal disease

11 November 2017

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Effects of uremic serum and uremic toxins on hepatic uptake of digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

A pharmacokinetic analysis program (multi) for microcomputer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Cytochrome P4502C9 activity in end‐stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Effects of uremic toxins on hepatic uptake and metabolism of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

Downregulation of intestinal cytochrome p450 in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.62.01.0015

21 January 2018

Identifiers

DOI

10.1211/JPP.62.01.0015

1 reference

11 November 2017

1 reference